Clinical Trial Update: Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Buccal Film to IV Palonosetron for prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving MEC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Buccal Film
• Palonosetron (palonosetron)

Snippet

Sponsor: Xiamen LP Pharmaceutical Co., Ltd | Conditions: Chemotherapy-induced Nausea and Vomiting | Phase 3 | Status: UNKNOWN